Eric is a Senior Scientist specializing in microbiology, with a focus on mode-of-action studies in antibiotic discovery. His work examines bacterial responses to small molecules to support structure–activity relationship (SAR) analysis and data-driven decision-making.

He has over nine years of experience in drug discovery and has contributed to the antibiotic discovery pipeline Digibiotics at the University of Tromsø. In addition to SAR and microbiology, Eric supports data, and IT workflows, helping translate science into actionable insights for the discovery of novel antibiotics.